|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8640 EUR | -0.69% |
|
-1.71% | -26.66% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
Biological Products | ||||||
Biotechnology (Startups) | 39 | 22 | 2L | 46 | 188 | |
Total Assets | 36.85L | 23.95L | 39.71L | 36.1L | 36.63L | |
Interest Expense | -538 | -493 | -6.51T | -304 | -14.19T | |
Income Tax Expense | -1L | -4L | -4L | -6L | -5L | |
EBT | -11.2L | -29L | -41.12L | -27.16L | -38.58L | |
Operating Income | -9L | -30.83L | -42.3L | -27.9L | -38.73L | |
Net Income | -10L | -24.43L | -37.45L | -20.81L | -33.18L |
Geographical Revenue Distribution History
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
France | 39 | 22 | 2L | 46 | 188 | |
Total Assets | 36.85L | 23.95L | 39.71L | 36.1L | 36.63L | |
Interest Expense | -538 | -493 | -6.51T | -304 | -14.19T | |
Income Tax Expense | -1L | -4L | -4L | -6L | -5L | |
Net Income | -10L | -24.43L | -37.45L | -20.81L | -33.18L | |
EBT | -11.2L | -29L | -41.12L | -27.16L | -38.58L | |
Operating Income | -9L | -30.83L | -42.3L | -27.9L | -38.73L |
- Stock Market
- Stocks
- ALNFL Stock
- Financials NFL Biosciences
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
